Loss of HDAC6, a novel CHIP substrate, alleviates abnormal tau accumulation

Human Molecular Genetics

Volumn 21, Issue 13, 2012, Pages 2936-2945

  Cook, Casey ^a   Gendron, Tania F ^a   Scheffel, Kristyn ^a   Carlomagno, Yari ^a   Dunmore, Judy ^a   DeTure, Michael ^a   Petrucelli, Leonard ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXY TERMINUS OF HSP70 INTERACTING PROTEIN; HEAT SHOCK PROTEIN 90 INHIBITOR; HISTONE DEACETYLASE 6; TAU PROTEIN; UBIQUITIN PROTEIN LIGASE; UBIQUITINATED PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOUSE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ALZHEIMER DISEASE; ANIMALS; CELLS, CULTURED; HEK293 CELLS; HELA CELLS; HISTONE DEACETYLASES; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MICE; MICE, KNOCKOUT; RNA INTERFERENCE; RNA, SMALL INTERFERING; TAU PROTEINS; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84863508369     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds125     Document Type: Article

References (42)

1. Drubin, D.G., Feinstein, S.C., Shooter, E.M. and Kirschner, M.W. (1985) Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J. Cell Biol., 101, 1799-1807.
2. Esmaeli-Azad, B., McCarty, J.H. and Feinstein, S.C. (1994) Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J. Cell Sci., 107, 869-879.
3. Stamer, K., Vogel, R., Thies, E., Mandelkow, E. and Mandelkow, E.M. (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol., 156, 1051-1063.
4. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A. and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev., 33, 95-130.
5. Dickson, D.W. (1999) Tau and synuclein and their role in neuropathology. Brain Pathol., 9, 657-661.
6. Petrucelli, L., Dickson, D., Kehoe, K., Taylor, J., Snyder, H., Grover, A., De Lucia, M., McGowan, E., Lewis, J., Prihar, G. et al. (2004) CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet., 13, 703-714.
7. Shimura, H., Schwartz, D., Gygi, S.P. and Kosik, K.S. (2004) CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem., 279, 4869-4876.
8. Dickey, C.A., Yue, M., Lin, W.L., Dickson, D.W., Dunmore, J.H., Lee, W.C., Zehr, C., West, G., Cao, S., Clark, A.M. et al. (2006) Deletion of the ubiquitin ligase CHIP leads to the accumulation, but not the aggregation, of both endogenous phospho- and caspase-3-cleaved tau species. J. Neurosci., 26, 6985-6996.
9. Dickey, C.A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R.M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C.B. et al. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest., 117, 648-658.
10. Buchner, J. (1999) Hsp90 & Co.-a holding for folding. Trends Biochem. Sci., 24, 136-141.
11. Welch, W.J. and Feramisco, J.R. (1982) Purification of the major mammalian heat shock proteins. J. Biol. Chem., 257, 14949-14959.
12. Pratt, W.B., Gehring, U. and Toft, D.O. (1996) Molecular chaperoning of steroid hormone receptors. EXS, 77, 79-95.
13. Lattouf, J.B., Srinivasan, R., Pinto, P.A., Linehan, W.M. and Neckers, L. (2006) Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy. Nat. Clin. Pract. Urol., 3, 590-601.
14. Dickey, C.A., Dunmore, J., Lu, B., Wang, J.W., Lee, W.C., Kamal, A., Burrows, F., Eckman, C., Hutton, M. and Petrucelli, L. (2006) HSP induction mediates selective clearance of tau phosphorylated at proline-directed Ser/Thr sites but not KXGS (MARK) sites. FASEB J., 20, 753-755.
15. Kamal, A., Boehm, M.F. and Burrows, F.J. (2004) Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol. Med., 10, 283-290.
16. Isaacs, J.S., Xu, W. and Neckers, L. (2003) Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell, 3, 213-217.
17. Bali, P., Pranpat, M., Bradner, J., Balasis, M., Fiskus, W., Guo, F., Rocha, K., Kumaraswamy, S., Boyapalle, S., Atadja, P. et al. (2005) Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J. Biol. Chem., 280, 26729-26734.
18. Kovacs, J.J., Murphy, P.J., Gaillard, S., Zhao, X., Wu, J.T., Nicchitta, C.V., Yoshida, M., Toft, D.O., Pratt, W.B. and Yao, T.P. (2005) HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol. Cell, 18, 601-607.
19. Murphy, P.J., Morishima, Y., Kovacs, J.J., Yao, T.P. and Pratt, W.B. (2005) Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone. J. Biol. Chem., 280, 33792-33799.
20. Scroggins, B.T., Robzyk, K., Wang, D., Marcu, M.G., Tsutsumi, S., Beebe, K., Cotter, R.J., Felts, S., Toft, D., Karnitz, L. et al. (2007) An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell, 25, 151-159.
21. Rao, R., Fiskus, W., Yang, Y., Lee, P., Joshi, R., Fernandez, P., Mandawat, A., Atadja, P., Bradner, J.E. and Bhalla, K. (2008) HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood, 112, 1886-1893.
22. Yang, Y., Rao, R., Shen, J., Tang, Y., Fiskus, W., Nechtman, J., Atadja, P. and Bhalla, K. (2008) Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. Cancer Res., 68, 4833-4842.
23. Amolins, M.W. and Blagg, B.S. (2009) Natural product inhibitors of Hsp90: potential leads for drug discovery. Mini Rev. Med. Chem., 9, 140-152.
24. George, P., Bali, P., Annavarapu, S., Scuto, A., Fiskus, W., Guo, F., Sigua, C., Sondarva, G., Moscinski, L., Atadja, P. et al. (2005) Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. Blood, 105, 1768-1776.
25. Xu, W., Marcu, M., Yuan, X., Mimnaugh, E., Patterson, C. and Neckers, L. (2002) Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2/Neu. Proc. Natl Acad. Sci. USA, 99, 12847-12852.
26. Ding, H., Dolan, P.J. and Johnson, G.V. (2008) Histone deacetylase 6 interacts with the microtubule-associated protein tau. J. Neurochem., 106, 2119-2130.
27. Luo, W., Dou, F., Rodina, A., Chip, S., Kim, J., Zhao, Q., Moulick, K., Aguirre, J., Wu, N., Greengard, P. et al. (2007) Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies. Proc. Natl Acad. Sci. USA, 104, 9511-9516.
28. Dickey, C.A., Eriksen, J., Kamal, A., Burrows, F., Kasibhatla, S., Eckman, C.B., Hutton, M. and Petrucelli, L. (2005) Development of a high throughput drug screening assay for the detection of changes in tau levels - proof of concept with HSP90 inhibitors. Curr. Alzheimer Res., 2, 231-238.
29. Ciechanover, A. (1994) The ubiquitin-proteasome proteolytic pathway. Cell, 79, 13-21.
30. Heltweg, B., Dequiedt, F., Marshall, B.L., Brauch, C., Yoshida, M., Nishino, N., Verdin, E. and Jung, M. (2004) Subtype selective substrates for histone deacetylases. J. Med. Chem., 47, 5235-5243.
31. McLaughlin, S.H., Sobott, F., Yao, Z.P., Zhang, W., Nielsen, P.R., Grossmann, J.G., Laue, E.D., Robinson, C.V. and Jackson, S.E. (2006) The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J. Mol. Biol., 356, 746-758.
32. Connell, P., Ballinger, C.A., Jiang, J., Wu, Y., Thompson, L.J., Hohfeld, J. and Patterson, C. (2001) The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol., 3, 93-96.
33. Boyault, C., Zhang, Y., Fritah, S., Caron, C., Gilquin, B., Kwon, S.H., Garrido, C., Yao, T.P., Vourc'h, C., Matthias, P. et al. (2007) HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev., 21, 2172-2181.
34. Westerheide, S.D. and Morimoto, R.I. (2005) Heat shock response modulators as therapeutic tools for diseases of protein conformation. J. Biol. Chem., 280, 33097-33100.
35. Kim, Y.S., Alarcon, S.V., Lee, S., Lee, M.J., Giaccone, G., Neckers, L. and Trepel, J.B. (2009) Update on Hsp90 inhibitors in clinical trial. Curr. Top. Med. Chem., 9, 1479-1492.
36. Xu, W. and Neckers, L. (2007) Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells. Clin. Cancer Res., 13, 1625-1629.
37. Kamal, A. and Burrows, F.J. (2004) Hsp90 inhibitors as selective anticancer drugs. Discov. Med., 4, 277-280.
38. Biamonte, M.A., Shi, J., Hong, K., Hurst, D.C., Zhang, L., Fan, J., Busch, D.J., Karjian, P.L., Maldonado, A.A., Sensintaffar, J.L. et al. (2006) Orally active purine-based inhibitors of the heat shock protein 90. J. Med. Chem., 49, 817-828.
39. Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M.F., Fritz, L.C. and Burrows, F.J. (2003) A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature, 425, 407-410.
40. Perez, M., Santa-Maria, I., Gomez de Barreda, E., Zhu, X., Cuadros, R., Cabrero, J.R., Sanchez-Madrid, F., Dawson, H.N., Vitek, M.P., Perry, G. et al. (2009) Tau-an inhibitor of deacetylase HDAC6 function. J. Neurochem., 109, 1756-1766.
41. Takemura, R., Okabe, S., Umeyama, T., Kanai, Y., Cowan, N.J. and Hirokawa, N. (1992) Increased microtubule stability and alpha tubulin acetylation in cells transfected with microtubule-associated proteins MAP1B, MAP2 or tau. J. Cell. Sci., 103, 953-964.
42. Dai, Q., Zhang, C., Wu, Y., McDonough, H., Whaley, R.A., Godfrey, V., Li, H.H., Madamanchi, N., Xu, W., Neckers, L., Cyr, D. and Patterson, C. (2003) CHIP activates HSF1 and confers protection against apoptosis and cellular stress. EMBO J, 22, 5446-5458.